These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 509234

  • 21. Biogenic amine-stimulated adenylate cyclase and spiroperidol-binding sites in rabbit brain: evidence for selective loss of receptors with aging.
    Makman MH, Ahn HS, Thal LJ, Dvorkin B, Horowitz SG, Sharpless NS, Rosenfeld M.
    Adv Exp Med Biol; 1978; 113():211-30. PubMed ID: 753089
    [Abstract] [Full Text] [Related]

  • 22. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS, Burt DR, Barraclough CA.
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [Abstract] [Full Text] [Related]

  • 23. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ, Reches A, MacLeod RM, Login IS.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):229-34. PubMed ID: 6617744
    [Abstract] [Full Text] [Related]

  • 24. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
    Govoni S, Spano PF, Trabucchi M.
    J Pharm Pharmacol; 1978 Jul 22; 30(7):448-9. PubMed ID: 27613
    [No Abstract] [Full Text] [Related]

  • 25. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K, Unemi N, Segawa T.
    Arch Int Pharmacodyn Ther; 1985 Mar 22; 274(1):111-24. PubMed ID: 3925907
    [Abstract] [Full Text] [Related]

  • 26. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH.
    Am J Psychiatry; 1981 Apr 22; 138(4):460-4. PubMed ID: 6111227
    [Abstract] [Full Text] [Related]

  • 27. Detection of multiple receptors for dopamine.
    Spano PF, Memo M, Stefanini E, Fresia P, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Apr 22; 21():243-51. PubMed ID: 7376971
    [No Abstract] [Full Text] [Related]

  • 28. Characterization of D2 receptors and dopamine levels in the thalamus of the rat.
    Young KA, Wilcox RE.
    Life Sci; 1991 Apr 22; 48(19):1845-52. PubMed ID: 1645835
    [Abstract] [Full Text] [Related]

  • 29. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 22; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 30. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984 Apr 22; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 31. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L, Govoni S, Memo M, Missale C, Spano PF, Trabucchi M.
    Toxicol Lett; 1986 Sep 22; 32(3):255-60. PubMed ID: 3022429
    [Abstract] [Full Text] [Related]

  • 32. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M.
    Biochem Pharmacol; 1981 Nov 15; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract] [Full Text] [Related]

  • 33. Treatment with haloperidol or clozapine causes changes in dopamine receptors but not adenylate cyclase or protein kinase C in the rat forebrain.
    Wan DC, Dean B, Pavey G, Copolov DL.
    Life Sci; 1996 Nov 15; 59(23):2001-8. PubMed ID: 8950299
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J, Tassin JP, Thierry AM, Glowinski J, Premont J.
    Brain Res; 1977 Feb 11; 122(1):71-86. PubMed ID: 837225
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1980 May 02; 63(2-3):135-44. PubMed ID: 6103813
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.